BAY85-3934

DRUG5 trials

Sponsors

Bayer

Conditions

AnemiaRenal Insufficiency, Chronic

Phase 1

Single Dose Group Stratified Study in Renal Impaired and Healthy Aged and Gender Matched Subjects

CompletedNCT01318551

Start: 2011-03-16End: 2014-08-14Updated: 2021-01-27

Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease)

CompletedNCT01332942

Start: 2011-04-30End: 2013-12-31Updated: 2015-07-14

Age and Gender Effects on the Pharmacokinetics of BAY85-3934

CompletedNCT01458028

Start: 2011-09-30End: 2011-12-31Updated: 2014-05-06

Phase 2

Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934

CompletedNCT02021409

BayerAnemia, Renal Insufficiency, Chronic

Start: 2014-01-28End: 2015-11-23Updated: 2019-09-19

15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)

CompletedNCT02021370

BayerAnemia, Renal Insufficiency, Chronic

Start: 2014-02-10End: 2015-09-23Updated: 2019-09-20